Storage and handling
Other Information store at 15° to 30° C (59° to 86° F), away from heat
Other Information store at 15° to 30° C (59° to 86° F), away from heat
Active Ingredient
Salicylic acid 40%
Purpose
Corn and callus remover
Uses
For the removal of corns and calluses
Relieves pain by removing corns and calluses
Warnings
For external use only
Allergy alert: This product contains natural rubber latex which may cause allergic reactions
Do not use
on irritated skin
on any area that is infected or reddened
if you are a diabetic
if you have poor blood circulation
Stop use and ask a doctor or podiatrist if
discomfort persists
nausea, vomiting, abdominal discomfort, diarrhea, or skin rash occurs
Keep out of reach of children.
If swallowed, get medical help or contact an Poison Control Center right away.
Directions
wash affected area and dry thoroughly
apply medicated plaster over corn or callus
after 48 hours remove the medicated plaster
repeat this procedure every 48 hours as needed for up to 14 days (until corn/callus is removed)
Other Information
store at 15° to 30° C (59° to 86° F), away from heat
Inactive Ingredients
Lanolin, paraffin, petrolatum, phenol, and zinc oxide, mounted in a natural rubber latex ring on adhesive fabric with a polyethylene film cover.
Questions or Comments? (888) 221-3496 M-F 9am to 5p
Yat Tip Tor
Corn & Callus Remover
NDC 61822-0047-1
10 Plasters
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61822-0047-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-29fe-a910-e053-dadaa90a0b85 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61822-0047-1 | YAT TIP TOR | 10 in 1 BOX | PLASTER | 10 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61822-0047 | YAT TIP TOR (SALICYLIC ACID) PLASTER [GUANGZHOU BAIYUNSHAN PHARMACEUTICAL CO., LTD. BAIYUNSHAN HEJIGONG PHARMACEUTICAL FACTORY] | 2 | Legacy NDC, 1 package rows | 20191114_ff52ba65-268b-46ce-8008-148955bb2720.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| LANOLIN | INACTIVE INGREDIENT | 7EV65EAW6H | 1 | |
| PARAFFIN | INACTIVE INGREDIENT | I9O0E3H2ZE | 1 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| PHENOL | INACTIVE INGREDIENT | 339NCG44TV | 1 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61822-0047 | 61822-0047-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| LANOLIN | 7EV65EAW6H | IACT |
| PARAFFIN | I9O0E3H2ZE | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| PHENOL | 339NCG44TV | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PHENOL | PHENOL | 339NCG44TV | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 2 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 2 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| PHENOL | PHENOL | 339NCG44TV | LIQUID / SUBCUTANEOUS | 0.5 %w/v | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SPRAY / NASAL | NA | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| PHENOL | PHENOL | 339NCG44TV | DOUCHE / VAGINAL | 0.14 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / OPHTHALMIC | 3 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION / INTRAMUSCULAR | 48 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | LOTION / TOPICAL | 1.5 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, DELAYED RELEASE / ORAL | 0.2 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | SUSPENSION / TOPICAL | 11726 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION / INTRA-ARTICULAR | 0.5 %w/v | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | CAPSULE, EXTENDED RELEASE / ORAL | 100 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / VAGINAL | 2 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, COATED / ORAL | 0.07 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | CREAM / TOPICAL | 300 mg | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION / INTRALESIONAL | 0.5 %w/v | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION / INTRAVENOUS | 48 mg | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION, SOLUTION / INTRAMUSCULAR | 75 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SHAMPOO / TOPICAL | 2 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / TOPICAL | 10 mg | ||
| PHENOL | PHENOL | 339NCG44TV | LIQUID / INTRAVENOUS | 0.5 %w/v | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION / INTRASYNOVIAL | 0.5 %w/v | ||
| PHENOL | PHENOL | 339NCG44TV | SOLUTION / INTRAVENOUS | 23 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | AEROSOL, FOAM / TOPICAL | 14235 mg | ||
| PHENOL | PHENOL | 339NCG44TV | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION / INTRADERMAL | 0.25 %w/v | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET / ORAL | 0.7 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | SOAP / TOPICAL | 0.4 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, EXTENDED RELEASE / ORAL | 321 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | OINTMENT / RECTAL | 38 mg | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2 mg | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION, SOLUTION / INTRAVENOUS | 75 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / RECTAL | 105 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| PHENOL | PHENOL | 339NCG44TV | INJECTION, SOLUTION / SUBCUTANEOUS | 0.55 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3c82da50-81fc-45d0-8c8a-8737660739ca | ff52ba65-268b-46ce-8008-148955bb2720 | 2019-11-13 | Warnings | 3c82da50-81fc-45d0-8c8a-8737660739ca ff52ba65-268b-46ce-8008-148955bb2720 |
Adverse event summaries are temporarily unavailable. Other product information remains available.